Epstein Secrets

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

sing 60 hourly data points, correlation has moved from around -80% a month ago to =ero now. This means the volatility of risk parity portfolios are increasin= and rebalancing is required. Chart Two: Investm=nt Grade ETF, LQD, is at the top of a long term channel with shares outsta=ding around an all time

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

sing 60 hourly data points, correlation has moved from around -80% a month ago to =ero now. This means the volatility of risk parity portfolios are increasin= and rebalancing is required. </=pan> Chart Two: Investm=nt Grade ETF, LQD, is at the top of a long term channel with shares outsta=ding around an a

EVA's positioning in generic pharma where scale and pro=uct diversity are increasingly important. TEVA remains one of our top pick= in Spec Pharma. Frontier Comm (FTR) - BAM= reaffirming BUY after Frontier reported its first post-Verizon assets merger results. =TR's earnings miss was due to a decline in the l

sing 60 hourly data points, correlation has moved from around -80% a month ago to =ero now. This means the volatility of risk parity portfolios are increasin= and rebalancing is required. Chart Two: Investm=nt Grade ETF, LQD, is at the top of a long term channel with shares outsta=ding around an all time